About Us
Company Introduction Strategic Development Social Responsibility
Scientific Research
Innovative Layout Innovative Field
International
Global Expansion Cooperative Partner Global R&D Centers International Cooperation
Investor Relations
Information Disclosure Corporate Governance Stock Information ESG Contact us
Products Services
Product center Product branding Quality & Safety
News
Company News Media Coverage Media Inquiries Multimedia zone
Career
Talent R&D Team Employee Life Job Opportunities
EN
CN
About Us
· Company Introduction · Strategic Development · Social Responsibility
Scientific Research
· Innovative Layout · Innovative Field
Products Services
· Product center · Product branding · Quality & Safety
News
· Company News · Media Coverage · Media Inquiries · Multimedia zone
Vocational
· Concept about Talent · R&D Team · Employee Life · Job Opportunities
> News > Company
Return
Grand Pharma Fuchi Industrial Park Successfully Evaluated as Class D Park, Opening a New Chapter of Safety Development
2024-12-30

Recently, Grand Pharma Fuchi Industrial Park has successfully passed the inspection and evaluation by the provincial expert group of Grade C to Grade D, and was formally approved as a Grade D park, marking a major breakthrough in safety management and overall improvement of the park.

Since the release of the Hubei Provincial Safety Committee’s ‘Three-Year Action Programme for Safety Improvement in the Province’s Chemical Parks’, Fuchi Industrial Park has actively responded to the call.

With the strong support of Yangxin County People’s Government, Grand Pharma, together with relevant functional departments of Yangxin County and Fuchi Town Government, quickly set up a task force and fully committed to the creation of Class D park.

In July this year, facing the detailed inspection by the expert group of Provincial Emergency Management Department and Provincial Hazardous Chemicals Association, the park highly cooperated with the expert group, which carried out an all-round and deep investigation on the enterprises in the park around the six core areas of park planning, public works, safety management, chemical safety, fire fighting and emergency response, and information technology and closed management, based on 36 detailed standards.

In addition, the park has increased investment in safety construction, in which the Safety Intelligent Management Intelligent Control Platform was successfully launched at the end of October this year. The platform makes full use of advanced technological means, which greatly improves the park’s safety management efficiency, realises real-time monitoring of the park’s safety conditions and accurate early warning; and the construction of a special car park for hazardous chemicals builds up a solid line of defence for the safety of the park’s logistics.

On 12 November, the park successfully passed the inspection and evaluation by the provincial expert group of C grade to D grade. This achievement is not only a high affirmation of Fuchi Industrial Park’s long-term safety management work, but also a push for the park to move towards a higher quality development stage.

In the future, the park will uphold the concept of safety first and green development, optimise the management mode, improve the service level, and strive to become a green and safe provincial demonstration park, and play a leading role in the province’s chemical parks’ safety improvement and sustainable development.

Prev

Next

Related news

  • Grand Pharma’s Global Innovative Ophthalmic Drug CBT-001 Completes the Enrollment of All Patients in the International Multi-Center Phase III Clinical Trial
    Grand Pharma’s Global Innovative Ophthalmic Drug CBT-001 Completes the Enrollment of All Patients in the International Multi-Center Phase III Clinical Trial

    2025-06-05

  • Grand Pharma’s Global Innovative Product for the Treatment of Demodex Blepharitis Is Approved for Commercialization by Macao ISAF of China
    Grand Pharma’s Global Innovative Product for the Treatment of Demodex Blepharitis Is Approved for Commercialization by Macao ISAF of China

    2025-05-30

  • Update on Strategic Investment in Telix
    Update on Strategic Investment in Telix

    2025-03-01

Grand Pharma Group
About Us
Company Introduction Strategic Development Social Responsibility
Scientific Research
Innovative Layout Innovative Field
International
Global expansion Cooperative Partner Global R&D Centers International Cooperation
Investor Relations
Information Disclosure Corporate Governance Stock Information Contact us
Products Services
Product Center Product branding Quality & Safety
News
Company News Media Coverage Media Inquiries Multimedia zone
Vocational
Concept about Talent R&D Team Employee Life Job Opportunities
Copyright © Grand Pharma (China) Co., Ltd. All Rights Reserved E ICP B 10008288 EGWAB 42010402000597
Legal Provisions